| Line Item | 2025-11-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $16.06B | +7.6% | +14.2% |
| R&D Expense | $2.56B | +2.8% | +3.6% |
| SG&A Expense | $409.0M | +8.8% | +5.7% |
| Operating Income | $4.73B | +10.6% | +12.1% |
| Interest Expense | $1.06B | +14.5% | +22.1% |
| Income Tax | $207.0M | -58.6% | -13.4% |
| Net Income | $6.13B | +109.6% | +94.7% |
| EPS (Basic) | $2.14 | +105.8% | +89.4% |
| EPS (Diluted) | $2.10 | +107.9% | +90.9% |
| Line Item | 2025-11-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $19.24B | +84.2% | +75.9% |
| Accounts Receivable | $9.44B | +6.8% | +15.4% |
| Current Assets | $34.37B | +39.5% | +46.2% |
| Total Assets | $204.98B | +13.6% | +38.1% |
| Current Liabilities | $37.80B | -5.2% | +30.1% |
| Stockholders' Equity | $29.95B |
| Line Item | 2025-11-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $10.21B | +25.4% | — |
| Capital Expenditures | $20.54B | +141.5% | — |
| Investing Cash Flow | -$16.43B | -88.5% | — |
| Financing Cash Flow | $14.70B | +6898.6% | — |
| Free Cash Flow | -$10.33B | -2753.3% | — |
| +24.0% |
| +117.9% |